Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.10/1521
Título: Selection of colon cancer patients for neoadjuvant chemotherapy based on optimised preoperative MDCT A prospective multi-observer radiologic-pathologic agreement study
Autor: Rosado, E
Germano, A
Costa, A
Manso, RT
Gomes, A
Leichsenring, C
Santiago, I
Palavras-chave: Colorectal neoplasms
Neoadjuvant therapy
Computed tomography
Data: 2015
Editora: European Society of Radiology
Citação: EUROPEAN CONGRESS OF RADIOLOGY, Vienna, 4-8 March 2015
Resumo: PURPOSE: Neoadjuvant chemotherapy (NACT) in potencially-resectable locally advanced colon cancer (LACC) is likely to prove superiority compared to standard treatment in the phase III FOXTROT Collaborative Group Trial. Thus, identification of LACC, defined as T3≥5 mm or T4, is fundamental and requires accurate noninvasive imaging. The value of optimized preoperative MDCT for that purpose is being assessed. METHODS AND MATERIALS: Observational, cross-sectional, prospective study including all patients with colon cancer refered to our Institution´s Radiology Department for preoperative staging between the 1st of October 2013 and the 6th of August 2014. Independent reading of optimized MDCT acquisitions using MPR was performed by 4 radiologists (3.6,15 and 20 years of experience in gastrointestinal imaging). Extramural tumour extension was graded as < 5 mm; ≥5 mm; invasion of peritoneum/fascia/adjacent organ. Surgical specimen analysis was performed by a single pathologist with 12 years of experience in gastrointestinal pathology. Radiologic-Pathologic agreement was assessed. RESULTS: 48 patients, 26 males and 22 females, with a median age of 74 years (min:45;max:89) were considered eligible. Median time to surgery was 30.5 days (min:1;max:117). Diagnostic sensitivity, specificity, positive predictive value, negative predictive value and accuracy of MDCT for the identification of LACC ranged between 0.64 and 0.82; 0.84 and 0.92; 0.5 and 0.7; 0.88 and 0.97; 0.75 and 0.88; respectively. Mean agreement between observers was 0.88 (SD:0.17) per patient. CONCLUSION: Preliminary results suggest that optimized MDCT is a specific, accurate and reproducible method for the selection of colon cancer patients who may benefit from NACT, with minimal risk of overtreatment of low-risk patients.
Peer review: yes
URI: http://hdl.handle.net/10400.10/1521
Aparece nas colecções:ANPAT - Comunicações e Conferências
CIR - Comunicações e Conferências
IMAG - Comunicações e Conferências

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
ECR2015_B-0735.pdf725,57 kBAdobe PDFVer/Abrir

FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.